Back to search

University of Glasgow

An Investigation of the Potential Anti-Tumour Effects of a Tumour Cell-Line Engineered to Secrete Cytokines

Abstract

dc:description.abstract

Systemic administration of cytokines such as IL-2, IL-4 and the interferons have been extensively examined in animal models and clinically to assess their potential as anticancer drugs. To date, the promising results from animal studies have not been reproduced in clinical trials. The systemic administration of cytokines in cancer therapy is also complicated by serious side-effects because of the potency of these compunds. New routes of administering cytokines are therefore being investigated in order to prevent these side-effects and thus allow higher doses of drug to be administered. Routes of administration such as peritumoural, isolated limb perfusion, lymphokine activated killer cells and tumour infiltrating lymphocytes have all been tested clinically with various degrees of success.

Degree

thesis:*
Level dc:type.qualificationlevel
MSc(R)
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
1997

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Spence, Margaret Anne

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Spence, Margaret Anne. An Investigation of the Potential Anti-Tumour Effects of a Tumour Cell-Line Engineered to Secrete Cytokines. MSc(R) thesis, University of Glasgow, 1997.